Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

A Peninsula biotech company focusing on a deadly lung-scarring disease lost more than half its stock value Monday after ...

Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 trial of its lead drug for idiopathic pulmonary fibrosis (IPF) after seeing a ...

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

Experts in Türkiye warn that the increasing rate of smoking poses a serious public health threat, with children and teens ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

An Oxford NHS trust has offered its advice for coping with conditions like asthma and chronic obstructive pulmonary disease (COPD), which can worsen during the colder months.

One Conway woman is continuing to fight for her life after being diagnosed with Pulmonary Fibrosis in her battle with long ...

Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...

Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, ...

A COLD snap due to descend on the UK this weekend could prove deadly for millions with a common health condition, a charity ...